(Note: this is distinct from the separate TRANSCEND-T2D program below, which targets diabetes specifically rather than obesity-with-diabetes.) TRIUMPH-3: Obesity with Established Cardiovascular Disease Ongoing, results expected later 2026
Gluten-free and dairy-free, as confirmed by testing
To further achieve robust single-cell and 3D tissue imaging in the future, breakthroughs are still needed in terms of detection sensitivity, spatial resolution, and sample preparation methods to fully realize the application potential of high-spatial-resolution MALDI-MSI in the biological sciences
Brevetti G, Perna S, Sabba C, Martone VD, Condorelli M
Split dosing is primarily feasible with compounded semaglutide vials where you draw up specific volumes using an insulin syringe
For example, in the SURMOUNT-1 Trial, people taking Mounjaro over 72 weeks noticed an average reduction in body weight of 15% (4)